Drug · DIN 02530686 · Veterinary
APOQUEL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 19, 2023; first marketed July 19, 2023.
- Drug Identification Number (DIN)
- 02530686
- Company (DIN owner)
- Zoetis Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Chewable)
- Route
- Oral
- Class
- Veterinary
- Record last updated
- April 21, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OCLACITINIB (OCLACITINIB MALEATE) | 16 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 20, 2024: NOC 32914Supplement to a New Drug Submission (SNDS) · Addition of a drug substance supplier
- September 14, 2022: NOC 28948Supplement to a New Drug Submission (SNDS) · New dosage form (chewable tablets)
Other DINs named APOQUEL
- DIN 02427885 · Marketed
- DIN 02427893 · Marketed
- DIN 02427907 · Marketed
- DIN 02530651 · Marketed
- DIN 02530678 · Marketed